Navegar

Colección

Datos Estadísticas

Lista de

tumor microenvironment
44
"Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice" (2019) Zubeldía-Brenner, L.;De Winne, C.;Perrone, S. (...)Becu-Villalobos, D. Endocrine-Related Cancer. 26(1):13-29
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment" (2018) Elola, M.T.;Ferragut, F.;Méndez-Huergo, S.P. (...)Rabinovich, G.A. Cellular Immunology. 333:34-45
"Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment" (2018) Elola, M.T.;Ferragut, F.;Méndez-Huergo, S.P. (...)Rabinovich, G.A. Cellular Immunology. 333:34-45
"Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod" (2018) Rocco, R.;Alegre, N.;Pozner, R. (...)Gazzaniga, S. Toxicology Letters. 288:82-88
"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334
"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334
"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334
"VIP induces the decidualization program and conditions the immunoregulation of the implantation process" (2018) Grasso, E.;Gori, S.;Paparini, D. (...)Ramhorst, R. Molecular and Cellular Endocrinology. 460:63-72
"Comparative proteomics of soluble factors secreted by human breast adipose tissue from tumor and normal breast" (2018) Fletcher, S.J.;Hapon, M.B.;Callegari, E.A. (...)Pistone-Creydt, V. Oncotarget. 9(57):31007-31017
"Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer" (2018) Salatino, M.; Girotti, M.R.; Rabinovich, G.A. Cancer Cell. 33(2):155-157
"Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity" (2018) Corapi, E.; Carrizo, G.; Compagno, D.; Laderach, D. Frontiers in immunology. 9:2190
"In vivo hemin conditioning targets the vascular and immunologic compartments and restrains prostate tumor development" (2017) Jaworski, F.M.;Gentilini, L.D.;Gueron, G. (...)Vazquez, E.S. Clinical Cancer Research. 23(17):5135-5148
"Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma" (2017) Vase, M.;Ludvigsen, M.;Bendix, K. (...)D'Amore, F. AIDS. 31(16):2311-2313
"Mathematical modelling of microtumour infiltration based on in vitro experiments" (2016) Luján, E.;Guerra, L.N.;Soba, A. (...)Suárez, C. Integrative Biology (United Kingdom). 8(8):879-885
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"Phototriggered fibril-like environments arbitrate cell escapes and migration from endothelial monolayers" (2016) Salierno, M.J.;García-Fernandez, L.;Carabelos, N. (...)Campo, A.D. Biomaterials. 82:113-123
"Inflammation Controls Sensitivity of Human and Mouse Intestinal Epithelial Cells to Galectin-1" (2016) Muglia, C.I.;Papa Gobbi, R.;Smaldini, P. (...)Docena, G.H. Journal of Cellular Physiology. 231(7):1575-1585
"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54
"Dendritic cell-based vaccination in cancer: Therapeutic implications emerging from murine models" (2015) Mac Keon, S.; Ruiz, M.S.; Gazzaniga, S.; Wainstok, R. Frontiers in Immunology. 6(MAY)
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96
"Human adipose tissue from normal and tumoral breast regulates the behavior of mammary epithelial cells" (2013) Pistone Creydt, V.;Fletcher, S.J.;Giudice, J. (...)Calvo, J.C. Clinical and Translational Oncology. 15(2):124-131
"Human periprostatic adipose tissue: Its influence on prostate cancer cells" (2012) Sacca, P.A.;Creydt, V.P.;Choi, H. (...)Calvo, J.C. Cellular Physiology and Biochemistry. 30(1):113-122
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880